Monkeypox vaccines no longer need registration in Brazil

Brazil’s drug regulator Anvisa on Friday (Aug 19) unanimously decided to lift registration requirements for the import of drugs and vaccines aimed at preventing and treating monkeypox. In practice, the resolution should simplify document assessment and increase Brazilian’s access to medicines and shots for the treatment and prevention of the disease, given the public health […]

Fonte